49 filings
15-12G
REUN
Reunion Neuroscience Inc.
18 Aug 23
Securities registration termination
12:56pm
6-K
REUN
Reunion Neuroscience Inc.
1 Aug 23
Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement
10:54am
F-10POS
REUN
Reunion Neuroscience Inc.
1 Aug 23
Automatic registration of securities (post-effective amendment, Canada)
9:53am
S-8 POS
REUN
Reunion Neuroscience Inc.
1 Aug 23
Registration of securities for employees (post-effective amendment)
9:52am
S-8 POS
REUN
Reunion Neuroscience Inc.
1 Aug 23
Registration of securities for employees (post-effective amendment)
9:50am
25-NSE
13c4pmocvp2k9
1 Aug 23
Exchange delisting
9:17am
6-K
x5odkt19gn nexve
19 Jul 23
Current report (foreign)
5:17pm
6-K
65juygwu3f
13 Jul 23
Reunion Neuroscience Inc. Shareholders Approve Proposed Plan of Arrangement
4:30pm
6-K
izikxtq
7 Jul 23
Current report (foreign)
4:30pm
40-F
skfwkmdxbmwyvuwbepz
29 Jun 23
Annual report (Canada)
7:30am
6-K
rnk35u
20 Jun 23
Notice of Special Meeting of Shareholders
4:25pm
6-K
zfp7ba7x7
12 Jun 23
Material Change Report
4:30pm
6-K
am91a34fbn hfgbp
1 Jun 23
Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact
5:12pm
6-K
u2c 9ah4fya3u
25 Apr 23
Reunion Neuroscience Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
7:35am
6-K
m1lr3d6xrozyiey
13 Mar 23
Current report (foreign)
7:58pm
6-K
qb0v18n4cb
14 Feb 23
Unaudited Interim Consolidated Financial Statements
7:38am
6-K
rtbsj9uwgqn30kh5ins
9 Jan 23
Reunion Neuroscience Inc. Completes Interim Data Analysis for Phase 1 Clinical Trial with Novel Serotonergic Psychedelic RE104
7:35am
6-K
mmin2dhiijvmbiqnlm
4 Jan 23
Reunion Neuroscience Inc. Provides 2023 Corporate Update
4:32pm
6-K
b9jpw9rdd 9fg
28 Nov 22
Material Change Report
4:55pm
S-8
r8qtbfu8rk4
18 Nov 22
Registration of securities for employees
5:06pm